Human dendritic cells (DC) can now be generated in vitro in large numbers by culturing CD34 + hematopoietic progenitors in presence of GM-CSF+TNFet for 12 d. The present study demonstrates that cord blood CD34 + HPC indeed differentiate along two independent DC pathways. At early time points (day 5-7) during the culture, two subsets of DC precursors identified by the exclusive expression of CDla and CD14 emerge independently. Both precursor subsets mature at day 12-14 into DC with typical morphology and phenotype (CDS0, CD83, CD86, CD58, high HLA class II). CDla + precursors give rise to cells characterized by the expression of Birbeck granules, the Lag antigen and E-cadherin, three markers specifically expressed on Langerhans cells in the epidermis. In contrast, the CD14 + progenitors mature into CDla + DC lacking Birbeck granules, E-cadherin, and Lag antigen but expressing CD2, CD9, CD68, and the coagulation factor XIlla described in dermal dendritic cells. The two mature DC were equally potent in stimulating allogeneic CD45RA + naive T cells. Interestingly, the CD14 + precursors, but not the CDla + precursors, represent bipotent cells that can be induced to differentiate, in response to M-CSF, into macrophage-like cells, lacking accessory function for T ceils.
D
endritic cells (DC) 1 are professional antigen-presenting cells that are required for the initiation of immune responses (1) . Present at trace levels in all organs, DC are believed to function as sentinels of the immune system. Many types of DC with subtle differences in phenotype have been described in peripheral blood, skin, and lymphoid organs. In peripheral blood three different subsets of DC can be distinguished according to the expression of the surface antigens CD11c (2) or CD33 (3, 4) and CD83 (5) . In the skin, epidermal Langerhans cells (LC) and the so-called t Abbreviations used in this paper: DC, dendritic cells; HPC, hematopoietic progenitor cells; LC, Landerhans cells.
In this study we demonstrate that cord blood CD34 + HPC cultured with GM-CSF+TNF0~ develop along two independent DC pathways that, after 5-7 d of culture, can be identified at an immature stage according to CDla and CD14 expression. CDla + precursors yield, at day 12-14, DC related to LC characterized by the expression of CDla, E-cadherin, Lag antigen and Birbeck granules. In contrast, CD14 + precursors yield, at day 12-14, DC related to dermal dendrocytes or peripheral blood DC, characterized by the lack of Birbeck granules, E-cadherin, and Lag antigen and the expression ofCDla, CD2, CD9, CD68, and factor XIIIa.
Materials and Methods
Hematopoietic Factors. rhGM-CSF (specific activity: 2 • 10 a U/rag; Schering-Plough Research Institute, Kenilworth, NJ) was used at a saturating concentration of 100 ng/ml (200 U/ml). rhTNFct (specific activity: 2 • 107 U/rag; Genzyme, Boston, MA) was used at an optimal concentration of 2.5 ng/ml (50 U/ml) (20) rhSCF (specific activity 4 • 105 U/mg; R&D, Abington, UK) and rhM-CSF (specific activity: 2 • 106 U/mg; R&D) were used at optimal concentrations of 25 ng/ml. Umbil- ical cord blood samples were obtained according to institutional guidelines. Cells bearing CD34 antigen were isolated from mononuclear fractions (21, 22) through positive selection, using anti-CD34 rnAb (Immu-133.3, Immunotech, Marseille, France) and goat anti-mouse lgG-coated microbeads (Miltenyi Biotec GnU. H, Bergish Gladbach, Germany). Isolation of CD34 + progenitors was achieved using Mimmacs separation columns (Miltenyi Biotec GmbH) (23) . In all experiments the isolated cells were 80--99% CD34 + as judged by staining with anti-CD34 mAb. After purification, CD34 + cells were cryopreserved in 10% DMSO.
Collection and Purification of Cord Blood CD34 + HPC.

Purification of Cord Blood and Adult Peripheral Blood CD45RA + T Cells.
Mononuclear cells were isolated from adult peripheral blood or cord blood and depleted of adherent cells by overnight adherence to plastic, in complete medium, at 1 • l0 ~ cells per nil. CD45RA + T lymphocytes were then purified by immunomagnetic depletion using a cocktail of mAbs IOM2 (CD14), ION16 (CD16), and ION2 (HLA-DR) (hnmunotech, Marseille, France); NKH1 (CD56) and OKT8 (CD8)(Ortho Diagnostic System, P, aritan, NJ); and 4G7 (CD19), mAb 89, (CD40) (24) , and UCHL-1 (CD45R, O). After two rounds of bead depletion, the purity of CD45P, A + T cells was routinely higher than 95%.
Liquid Cultures for Dendritic Ceil Generation. Cultures were established in the presence of SCF, GM-CSF, and TNFo~, as described (15, 18) in endotoxin-free medium consisting of RPMI 1640 (GIBCO BRL, Gaithersburg, MD) supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum (FBS) (Flow Laboratories, Irvine, UK), 10 mM Hepes, 2 mM L-glutamine, 5 X 10 s M 2-mercaptoethanol, penicillin (100 U/ml) and streptomycin (100 Ng/ml) (referred to as complete medium).
After thawing, CD34 + cells were seeded for expansion in 25 to 75 cm 2 falcons (Corning, New York; NK) at 2 • 104 cells/ml. Optimal conditions were maintained by splitting these cultures at day 4 with medium containing fresh GM-CSF and TNFo~ (cell concentration: 1-3 • l0 s cells/ml). For most experiments cells were routinely collected after 5-6 d of culture for FACS|
holation qf CDIa and CDI4 DC Precursors by FACS|
After 5-6 d of culture in presence ofSCF, GM-CSF, TNFo~, cells were collected and labeled with FITC-conjugated OKT6 (CDla) (Ortho) and PE-conjugated Leu-M3 (CD14) (Becton Dickinson & Co., Mountain View, CA). Cells were separated according to CDla and CD14 expression into CD14+CDla , CD14-CD1a +, and eventually CD14-CD1a-fractions using a FACStarplus | (laser setting: power, 250 roW; excitation wavelength, 488 nm; Becton Dickinson). All the procedures of stamirlg and sorting were performed in presence of 5 mM EDTA in order to avoid cell aggregation..Reanalysis of the sorted populations showed a puri W higher than 98%.
Sorted cells were seeded in the presence of GM-CSF+TNFcl (1-2 • 105 cells per ml) for 6-7 additional days, a last medium change being performed at day 10. Cells were routinely collected between day 11 and day 14. Eventually adherent cells were recovered using a 5 mM EDTA solution.
ProlferationAssay. Cells at day 5-6 (CD14-CD1a +, CD14 + CDla-, CD14-CDla-) and total populations were seeded at 3 • 10 4 cells per well in round-bottomed microtest tissue culture plates in presence of medium alone, GM-CSF, TNFo~, GMCSF+TNFot or M-CSF. After 3 d of culture, cells were pulsed with 1 btCi of 3H-TdR (specific activity 25 Ci/mmol) per well, for the last 8 h, harvested and counted. Tests were carried out m triplicate, and results were expressed as mean counts per minute (cpm) + SD Cytofluorimetric Cell-Su{face Phenotypinq. Cells were processed for double staining (day 6) or single staining (day 12 sorted populations) using either uncoupled mAbs revealed by phycoewthnn (PE)-conjugated sheep F(ab')2 anti-mouse inmmnoglobulin (Ortho) or biotinylated mAbs revealed by PE-conjugated streptavidin (Becton Dickinson) or PE-conjugated mAbs. For double staining, after saturation in 5% mouse serum, cells were stained with OKT6 (anti-CDla)(Ortho) or Leu-M3 (anti-CDl4)(Becton Dickinson) mAbs directly labeled with FITC. Negative controls were performed with unrelated murine mAbs. Fluorescence analysis was determined with a FACScan | flow-cytometer (laser setting: power, 15 roW; excitation wavelength, 488 nm; Becton Dickinson), 5,000 events and 10,000 to 50,000 events were collected for single and double staining, respectively.
Immunostainings. Cells were cytocentrifuged for 4 rain at 400 rpm on a microscope slide. Some slides were used for May Griinwald Giemsa staining and the others were fixed in methanol/acetone at 20~ for l min for immunocytology. Slides were washed in PBS for 5 nfin and incubated with mAbs anti-CD68 (IgG3, Mo876, Dako) anti-Lag (IgG1, (25) ) and anti-S10013 (lgGl, $2532, Sigma) and a rabbit polyclonal anti-Factor XllIa (Nordic Immunological Laboratories, Tilburg, Netherlands) and mAh and polyclonal matched controls for 60 rain. The slides were washed twice in PBS. For CD68, slides were incubated with biotinylated sheep anti-mouse IgG3 for 30 min (PB276u; Binding Site, Birmingham, UK). For S100]3 and Lag, slides were incubated with biotinylated sheep anti-mouse IgG1 (PB273; Binding Site) for 30 nfin. For Factor XIIIa, slides were incubated with biotinylated goat anti-rabbit Ig (E432; Dako) for 30 rain. All stainings were then incubated with streptavidin coupled to alkaline phosphatase for 30 rain. The slides were washed three times in PBS and the enzyme activity was developed by the fast red substrate (Dako).
Electron Microscopy Proa'dures. Cells were recovered from day 6 to day 16. After washes, cells were directly fixed for 18 h with 2% glutaraldehyde in cacodylate buffer, then for l h with I% osmium tetroxide and embedded in epoxy medium after dehydration through a graded series of ethanols. Ultrathin sections were post-stained with uranyl acetate and lead citrate and examined on a JEOL 1200 EX electron microscope (CMEABG, Universit6 de Lyon, Lyon, France). A minimum of 100 cells of each population was analyzed for the presence of Birbeck granules.
T Cell Proliferation Assay. After 14 d of culture, CDla +-and CD14+-derived cells were collected and, after irradiation (30 Gy), used as stimulator cells for allogeneic CD45RA + naive adult or cord blood T cells (2 • 104 per well). From 10 to 104 stimulator cells were added to the T cells in 96-well round-bottomed microtest tissue-culture plates (Nunc, Roskilde, Denmark). Cultures were performed in RPMI 1640 medium supplemented with 10% heat-inactivated human AB + serum, and glutamine and antibiotics as above. After 5 d ofincubatiori, cells were pulsed with 1 ~Ci of 3H-TdR (specific activity 25 Ci/mmol) p~r well, for the last 8 h, harvested and counted. Tests were carried out in triplicate, and results were expressed as mean counts per rllitlute (cpm) + SD. The levels of 3H-TdR uptake by stimulator cells alone were always below 100 cpm.
Results
Identification of Two DC Precursor Subsets Based on Exclusive Expression of CDla and CD14.
In previous studies we have reported that cord blood CD34 + hematopoletic progenitor cells (HPC) cultured for 12 d m presence of GM-CSF+TNF~ yield DC characterized by the expression of CDla (15) . As addition of SCF allows a three-to fivefoid increase in cell numbers after 6 d of culture without altering cell differentiation (18, and unpublished observations), SCF was added from day 0 to day 6 in all cultures performed along this study. Herein, we have followed, using double color fluorescence, the kinetic of CDla and CD14 expression during the differentiation of CD34 + HPC cultured in the presence of GM-CSF+TNFo~ ( Fig. 1 A, pearing and at day 14, most cells lack CD14 and express CDla.
To confirm that CD14 + cells effectively acquired CDla and lost CD14, the two populations, CD14+CDla -and CD14-CD1a +, were FACS| at day 5-6. As shown in Fig. 1 B, upon reculture in GM-CSF+TNFcl for 7 additional days, the CD14+-derived cells expressed CDla and lack CD14. The CDla+-derived cells remained CD14--CDla +.
To better characterize the two populations, an extensive 80" Fig. 2 illustrates the major phenotypic differences observed between the two populations. Altogether, these results demonstrate that the two precursor populations, identified by the exclusive expression of CDla or CD14, differed by the expression of a set of molecules confirming that the two populations are unique and unrelated entities.
DC Precursors Do Not Proliferate but Differentiate into Mature DC.
To characterize the properties of the DC precursor populations and of their respective progenies, CD14 + and CDla + ceils were routinely FACS| after culturing CD34 + HPC with GM-CSF+TNF~+SCF for 5-6 d.
First the proliferative capacity of the two populations was assessed by comparison with that of CD14-CDlacells. Sorted cells were seeded at 3 • 104 cells per well in round-bottomed rnicrotest tissue culture plates with or without growth factors and the proliferation was assessed 3 d later by 3H-TdR uptake. As shown in Fig. 3 , both CD14--CDla + and CD14+CDla -failed to proliferate, while the double negative population strongly proliferated in response to GM-CSF or GM-CSF+TNFot. The lack of proliferative capacity of CD14+CDla -and CD14 CDla + populations was further confirmed in kinetic experiments based on the incorporation of Hoechst 33342 (not shown).
Thus, once the two precursors can be identified based on CDla and CD14 expression, they no longer can proliferate while the precursors lacking CDla and CD14 can still proliferate.
The differentiation potential of these two populations was then analyzed according to morphology and phenotype upon reculturing in presence of GM-CSF+TNFoL up until day 16. The morphology of the cells at different stages of culture/maturation is shown in Fig. 4 . At day 6, the two subsets contained a relatively homogeneous population of medium size with irregular shape (Fig. 4, A and E) . The CDla § DC developed a pronounced dendritic morphology at day 9, maintained at day 12 (Fig. 4, B--D) , with small dendrites homogeneously distributed over the cell surface. The dendritic morphology of CD14-derived DC developed at later time points (day 12 to day 16). The CD14+-derived DC are characterized by polarized lamellipodia (day 12, Fig. 4, F-H morphology can be observed at certain stages of differentiation (day 12-16, Fig. 4, F-I) .
In terms ofphenotype (Fig. 5 A) , at day 14 both populations yield cells expressing molecules expected on active DC including high levels of MHC class II, CD80, CD86, CD40, and the DC-specific marker CD83 and the intracytoplasmic molecule $100~3 (Fig. 6, A and B) . The two populations also expressed similar levels ofCDlc, CD4, CD1 la, CDllc, CD13, CD15s, CD18, CD33, CD43, CD44, CD45RO, CD48, CD49e, CD49d, CD50, CD54, CD58, CD59, CD71, CD74, CD78. The phenotype of mature DC was usually observed earlier on the CDla+-derived DC (day 10-12) than on the CD14+-derived DC (day 14--16) (not shown).
Taken together these results show that the two DC precursor populations isolated at day 5-6 differentiate, at day 12-16, into cells with a characteristic DC morphology and phenotype.
The Two DC Populations Display Different Characteristics.
Although the two cell populations have a phenotype characteristic of DC, some major phenotypic differences could be observed at day 14. As shown in Fig. 5 B, the CDla +-derived DC express low levels of CD72 and high levels of the E-cadherin, a molecule expressed on LC and involved in homophilic interactions between keratinocytes and LC in the epidermis (26, 27) . In addition, immunostaining (Fig. 6, C and D) show that CDla+-derived DC (19-34%) express the antigen Lag (Langerhans-associated granule, (25) ). On the contrary, CD14+-derived DC lack CD72, the Lag antigen and E-cadherin. Furthermore, in contrast to CDla-derived cells, CD14-derived cells display CD9, CD2, FCyRII/CD32, and the intracytoplasrmc CD68 (see also Fig. 6, E and F) . Finally, at day 14, CD14+-derived DC still express the complement receptor CD11b (12-35%) as well as CD36 (all the cells), not detected on CDla+-derived DC. At day 16-18 these two molecules were lost on CD14-derived DC (not shown). Also expression of Factor XIlla, a procoagulation factor described on dermal DC but not on epidermal LC, has been detected only on the CD14+-derived DC (Fig. 6, G and H) . The restricted expression of Factor XIIIa on the CD14 +-derived DC has been confirmed by RT-PC1K (not shown).
The two cell populations were also analyzed by electron microscopy. At day 13, the two cell populations had a characteristic dendritic cell shape and a typical multilobed nucleus. However, as shown in Fig. 7 , only the CDla +-derived DC were found to develop Birbeck granules. Between 12 and 14% of cells in the total population express Birbeck granules against 31-56% in the CDla+-derived DC population and 0--1% in the CD14+-derived DC population. In all experiments, and at any time point tested beyond day 6 (from day 13 to 16), the CDla+-derived DC Fig. 4 J, the M-CSF-derived cells, displayed a macrophage like morphology with numerous vacuoles, contrasting with the dendritic morphology of the G M -C S F + T N F o~-derived cells. These differentiation events occurred without proliferation as shown in Fig. 3 .
Thus, the CD14 + precursors display a double differentiation potential as they can be induced to differentiate into either D C in response to G M -C S F + T N F c x or macrophage-like cells in response to M-CSF. In contrast, the C D l a + precursors have a unique differentiation potential towards LC.
The Two DC Populations Are Equally Potent in Stimulating
Naive T Cell Proliferation. Activation of naive T cells being the functional characteristic of dendritic cells, the two mature D C populations were analyzed with regard to their ability to induce allogeneic CD451KA + naive T cells proliferation. C D 4 5 R A + naive T cells were isolated either from adult peripheral blood (Fig. 9 A) or from cord blood (Fig. 9 B) . At day 14, comparable stimulatory capacities of the two D C populations were observed. Half maximal proliferation of C D 4 5 R A + T cells from either adult or cord blood was obtained with 100-200 C D l a +-or CD14+-derived DC. As few as 10 cells of any populations were able to induce significant naive T cell proliferation (>100-fold background values). In contrast CD14+-derived cells recovered after M -C S F culture lacked stimulatory capacity for naive T cell proliferation (Fig. 9 C) . Between 3 X 103-104 ceils were required to induce a significant T cell proliferation, 1,000-fold more M-CSF-derived cells were required to induce levels of T cell proliferation observed with G MCSF+TNFc~-derived cells. Thus in addition to morphologic and phenotypic characteristics of dendritic cells C D l a +-and CD14+-derived cells have the functional property of dendritic cells, i.e., potent induction of naive T cell proliferation. lations, characterized by the reciprocal expression of CDla or CD14 antigens, emerge independently. Each precursor population expresses a unique pattern of surface molecules: CDla + precursors specifically bearing CD72 while CD14 + precursors express CD9, CD1 lb, CD36, and the M-CSF-R. In response to GM-CSF+TNF0t, both populations mature at day 12-16 into DC characterized by a dendritic morphology, a phenotype of DC (high HLA class I and II, CDla +, CD83 +, CD86 +, CD40 +, CD14-) and the capacity to activate naive CD45RA + cord blood T cells. The CDla-derived DC mature, at day 12, into typical LC according to the expression of Birbeck granules, intracytoplasmic Lag molecule and of surface E-cadherin, all borne by epidermal LC (25, 26, 27) . The CD14+-derived cells mature, at day 14-16, into DC that lack the LC antigens Lag and E-cadherin as well as Birbeck granules but express Factor XlIIa, CD11b, and CD36, markers of dermal (interstitial) dendritic cells (6, 7) . CD14+-derived DC, in contrast to CDla-derived DC, also express CD9 and CD2 molecules, which have been identified on circulating peripheral blood DC (2, 28, 29) .
Our study challenges the concept that the DC populations observed in vivo may indeed represent different stages of maturation/activation of the same DC lineage and raises the question about the relationship that exists between these in vitro DC populations, the in vivo ones and their specific early hematopoietic progenitors. Our results suggest that LC may represent an epithelial specific cell directly arising from precursors such as circulating CD34 + cells that could mature locally. By contrast, the circulating peripheral blood DC might represent cells in migration from the bone marrow to the peripheral organs (e.g., dermis, liver, kidney . . .) or from the peripheral organs to secondary lymphoid organs (e.g., spleen, lymph nodes). Our present findings would be consistent with the observations in rel-B knock-out mice which have normal LC but lack interdigitating cells (30, 31) .
The CDla+-derived DC (epithelial DC type) may represent an independent pathway of development unrelated to monocytes. In contrast, the CD14+-derived DC are likely linked to the monocyte lineage for the following reasons: (a) at certain stage of maturation, they share with monocytes, a number of molecules such as CD14, CD11b, CD36, and CD68; (b) they transiently display non-specific=esterase activity, a marker of scavengers while CDla-derived DC do not (manuscript in preparation); (c) upon M=CSF activation, CD14 + precursors differentiate into macrophagelike cells lacking accessory function for T cells, as recently described (32) , while CDla + precursors do not respond to M-CSF, presumably because of the absence of M-CSF-P, expression. In line with this hypothesis, peripheral blood monocytes which differentiate into macrophages in re- The existence of different pathway of DC development is indeed supported by the description, in mice, of thymic DC originating from hematopoietic precursors with a lymphoid differentiation potential contrasting with myeloid precursors yielding splenic DC (10, 14, 37) . In this context, a CD10 + CD34 + HPC able to differentiate into DC, T, B, and NK cells but not into myeloid cells has also been identified in humans (11) , thereby supporting the notion that one type of DC is developmentally more closely related to the lymphoid lineage than to the myeloid lineage. These cells might actually correspond to the presently described CDla+-derived DC which originates from early CD38 l~ CD34 + HPC (not shown). This CDla+-derived DC probably corresponds to the CFU-DC progenitor yielding pure DC colonies identified by Young et al. (38) . Further experiments are required to formally establish this hypothesis. On the contrary, the CD14+-derived DC are clearly developmentally linked to the myeloid lineage as illustrated by the isolation of CD14+CDla -common precursors that can yield either macrophages in response to M-CSF or dendritic cells in response to GM-CSF+TNFot. In summary, this study demonstrates that CD34 + HPC yield two separate precursors, CD14-CD1a + and CD14+CD1a -, that can differentiate without proliferating into phenotypically distinct dendritic cells respectively corresponding to epidermal and interstitial/dermal DC. 
